This statistic shows the revenue from antiretroviral drug formulations by Aurobindo Pharma Limited from financial years 2013 to 2018. As seen in the graph, the revenue from antiretroviral formulations for fiscal year 2018 was 8.4 billion Indian rupees. This was a drop in revenue compared to fiscal year 2016 which saw a revenue of 12.09 billion rupees.
Revenue from antiretroviral drug formulations by Aurobindo Pharma Limited from FY 2013 to FY 2018
(in billion Indian rupees)
Revenue in billion Indian rupees
-
-
-
-
-
-
-
-
-
-
-
-
Exclusive Premium statistic
You need a Premium Account for unlimited access.
Full access to 1m statistics
Incl. source references
Available to download in PNG, PDF, XLS format
Premium Account
only $59 / month
*
Access to this and all other statistics on 80,000 topics from
$708 / Year
Source
Only available for customers
Survey by
Only available for customers
Published by
Only available for customers
Source link
https://www.statista.com
Release date
April 2018
Region
India
Survey time period
FY 2013 to FY 2018
Special properties
India's fiscal year starts in April and ends in March. For example, FY 2018 started in April 2017 and ended in March 2018.
Supplementary notes
Note: ARV denotes antiretroviral drug formulations.
One Indian rupee is equal to 0.013 euros and 0.014 U.S. dollars (as of April 2019).
Revenue from ARV formulations of Aurobindo Pharma Limited 2012-2018
This statistic shows the revenue from antiretroviral drug formulations by Aurobindo Pharma Limited from financial years 2013 to 2018. As seen in the graph, the revenue from antiretroviral formulations for fiscal year 2018 was 8.4 billion Indian rupees. This was a drop in revenue compared to fiscal year 2016 which saw a revenue of 12.09 billion rupees.
This feature is limited to our corporate solutions.
Please contact us to get started with full access to dossiers, forecasts, studies and international data.
Corporate Account
Statista Accounts:
Access All Statistics. Starting from $708 / Year
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account!
Premium Account
Your perfect start with Statista
Instant access to 1m statistics
Download in XLS, PDF & PNG format
Detailed references
$59 / Month *
Corporate Account
Full access
Corporate solution including all features.
* All products require an annual contract.
Prices do not include sales tax.
Leading companies trust Statista:
Statista is a great source of knowledge, and pretty helpful to manage the daily work.
Do you have any questions about our business solutions?
We provide you with detailed information about our Corporate Account.
Statista Accounts:
Access All Statistics. Starting from $708 / Year
Learn more about how Statista can support your business.
Aurobindo Pharma. (April 8, 2018). Revenue from antiretroviral drug formulations by Aurobindo Pharma Limited from FY 2013 to FY 2018 (in billion Indian rupees) [Graph]. In Statista. Retrieved November 19, 2019, from https://www.statista.com/statistics/996262/india-aurobindo-pharma-arv-formulations-revenue/
Aurobindo Pharma. "Revenue from antiretroviral drug formulations by Aurobindo Pharma Limited from FY 2013 to FY 2018 (in billion Indian rupees)." Chart. April 8, 2018. Statista. Accessed November 19, 2019. https://www.statista.com/statistics/996262/india-aurobindo-pharma-arv-formulations-revenue/
Aurobindo Pharma. (2018). Revenue from antiretroviral drug formulations by Aurobindo Pharma Limited from FY 2013 to FY 2018 (in billion Indian rupees). Statista. Statista Inc.. Accessed: November 19, 2019. https://www.statista.com/statistics/996262/india-aurobindo-pharma-arv-formulations-revenue/
Aurobindo Pharma. "Revenue from Antiretroviral Drug Formulations by Aurobindo Pharma Limited from Fy 2013 to Fy 2018 (in Billion Indian Rupees)." Statista, Statista Inc., 8 Apr 2018, https://www.statista.com/statistics/996262/india-aurobindo-pharma-arv-formulations-revenue/
Aurobindo Pharma, Revenue from antiretroviral drug formulations by Aurobindo Pharma Limited from FY 2013 to FY 2018 (in billion Indian rupees) Statista, https://www.statista.com/statistics/996262/india-aurobindo-pharma-arv-formulations-revenue/ (last visited November 19, 2019)
We use cookies to personalize contents and ads, offer social media features, and analyze access to our website. In your browser settings you can configure or disable this, respectively, and can delete any already placed cookies. For details, please see your browser’s Help section (by pressing F1). Please see our privacy statement for details about how we use data.
